Breast Cancer‐Secreted DPP3 Promotes Lung Metastasis by Remodelling the Vascular Niche in Lung via the Rap1 Signalling Pathway
Journal of Extracellular Vesicles · 2025-12 · 14 (12)
DOI: 10.1002/jev2.70182 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 28.11.2025. Verfasst von Xu Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, TaiKang Center for Life and Medical Sciences, RNA Institute, Wuhan University, Wu…. Hauptthemen laut MEDLINE: Lung Neoplasms, Breast Neoplasms, Dipeptidyl-Peptidases and Tripeptidyl-Peptidases, rap1 GTP-Binding Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Science Foundation of Hubei Province, 2024AFD445, National Natural Science Foundation of China.
Abstract (Originalsprache)
Metastasis is the leading cause of death related to breast cancer. Premetastatic niches (PMNs), which are remodelled by the primary tumours in distant organs, are essential for the colonisation of disseminated cancer cells. The vascular niche is among the most pivotal PMNs in breast cancer lung metastasis, and the underlying mechanism remains unclear. Here, we report that breast cancer cells secrete dipeptidyl peptidase 3 (DPP3) via small extracellular vesicles (sEVs) to promote lung metastasis. Mechanistically, circulating DPP3 upregulates RAPGEF4 to activate the Rap1 signalling pathway in the lung endothelial cells through the DPP3–PFKP–YBX1 axis and promotes angiogenesis to remodel the vascular niche, thereby increasing lung metastasis. In addition, ARF4 recognises ISGylated DPP3, which facilitates its packaging into sEVs in breast cancer cells. Finally, treatment with losartan pharmacologically inhibits the ISGylation of DPP3, preventing its secretion via sEVs. In summary, our findings demonstrate that DPP3, which is encapsulated in sEVs and secreted by breast cancer cells, regulates angiogenesis in the lung and remodels vascular niches to promote breast cancer lung metastasis, making it a potential target for the diagnosis and treatment of breast cancer metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, TaiKang Center for Life and Medical Sciences, RNA Institute, Wuhan University, Wuhan, China.
- Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
ORCID-Profile: Wei Yan, Juanjuan Li
Förderung
- Natural Science Foundation of Hubei Province
- 2024AFD445
- National Natural Science Foundation of China
- 32270827, 82203590, 82472627
- Ministry of Science and Technology of the People's Republic of China
- 2021YFA0804803
Zitieren
APA
Li, X., Hu, S., Yuan, Z., Fu, X., Zhang, X., Liu, L., Wang, C., Yan, W., & Li, J. (2025). Breast Cancer‐Secreted DPP3 Promotes Lung Metastasis by Remodelling the Vascular Niche in Lung via the Rap1 Signalling Pathway. Journal of Extracellular Vesicles, 14(12). https://doi.org/10.1002/jev2.70182
Vancouver
Li X, Hu S, Yuan Z, Fu X, Zhang X, Liu L, et al. Breast Cancer‐Secreted DPP3 Promotes Lung Metastasis by Remodelling the Vascular Niche in Lung via the Rap1 Signalling Pathway. Journal of Extracellular Vesicles. 2025;14(12). doi:10.1002/jev2.70182
BibTeX
@article{Li2025,
author = {Li, Xu and Hu, Sheng and Yuan, Ziqi and Fu, Xiaoyu and Zhang, Xiaohui and Liu, Liu and Wang, Chaoqun and Yan, Wei and Li, Juanjuan},
title = {Breast Cancer‐Secreted DPP3 Promotes Lung Metastasis by Remodelling the Vascular Niche in Lung via the Rap1 Signalling Pathway},
journal = {Journal of Extracellular Vesicles},
year = {2025},
volume = {14},
number = {12},
doi = {10.1002/jev2.70182}
}
EUVIMED